The liver is at the centre of everything we do
A clinical stage life sciences company developing
end-to-end solutions for patients with advanced liver disease
Our Story
Pioneering the next paradigm in liver disease treatment
One critical path.
Three targets.
Three potential treatments.
Pipeline
Created by doctors for patients with advanced liver disease
We are poised to deliver clinical and commercial success
Team
16th Dec 2022
Study identifies a drug combination for the potential treatment of ACLF
8th Sep 2022
Queen Elizabeth II
15th Nov 2021
Yaqrit appoints a new Non-Executive Director
8th Oct 2021
Yaqrit is a finalist in the Annual OBN Awards for Best Established Medtech Company
31st Aug 2021
Introducing G-TAK, a novel combinatorial therapy for cirrhosis & ACLF
